Skip to content

Effect of the lesser trochanter involvement in trochanteric hip fractures

Effect of the lesser trochanter involvement in trochanteric hip fractures - The Lesser Trochanter study.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON44135
Enrollment
90
Registered
2016-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hipfracture trochanteric fracture

Interventions

None listed

Sponsors

Haaglanden Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Unilateral trochanteric fracture AO type 31 A1, A2 of A3. - Age * 70 years. - Fracture suitable for fixation with PFNa.

Exclusion criteria

Exclusion criteria: - Other fractures restricting rehabilitation. - High energy fracture of the hip. - Malignant fractures. - Previous fractures of the ipsi- or contralateral hip or femur. - Non operative treated hip fractures. - Injury Severity Score > 15. - Patients incapable of physical therapy for rehabilitation by dementia - Patients incapable of physical therapy for rehabilitation by physical restrictions.

Design outcomes

Primary

MeasureTime frame
The main endpoint of the study is the function and strength of the hip 12 months after surgery measured with the HHS.

Secondary

MeasureTime frame
* Pain measured with a visual analogue scale on day 2 and at 6 weeks, 3 and 12 months after surgery. * Migration of the lesser trochanter fragment on X-ray examinations in patients with trochanteric fractures with lesser trochanter involvement before surgery and at 6 weeks, 3 and 12 months after surgery. * Quality of life measured with a quality of life questionnaire (EQ-5D) before surgery and at 6 weeks, 3 and 12 months after surgery. * Duration of hospital stay (days). * Duration of rehabilitation centre stay (days). * Mental status measured with 6CIT-score before surgery and at 6 weeks and 12 months after surgery. * Patient reported general mobility measured with the Katz before surgery and at 6 weeks, 3 and 12 months after surgery. * The incidence and type of surgical related complications: deep and superficial wound infection, postoperative bleeding, 60-day and 1-year re-operation rate, and implant related failures (implant failure, implant dislocation, periprosthetic fracture). * The incidence and type of non-surgical related complications: hospital, 60-day and 1-year mortality delirium, pneumonia, cardiac complications, urinary tract infections, urinary retention, deep venous thrombosis, pulmonary embolism, pressure sores, and rate of underfeeding on admission (Mini Nutritional Assessment MNA).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)